Physician profile
Peteris Dzenis
NPI 1982637898
$3,318.38
in general payments reported to CMS, 2019-2025
13 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $121 · 2021: $281 · 2022: $203 · 2023: $518 · 2024: $1,749 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,281 · Travel and Lodging: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.37 |
| Travel and Lodging | $1,152.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,642.44 | 2019-2025 | Arcos, Persona, Rosa |
| Endo Pharmaceuticals INC. | $233.68 | 2019-2023 | Xiaflex |
| Stryker Corporation | $100.47 | 2019-2025 | Gamma |
| Depuy Synthes Sales INC. | $73.27 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $63.20 | 2019-2020 | |
| Fidia Pharma USA INC. | $62.46 | 2019 | |
| Pacira Therapeutics, INC. | $41.14 | 2020 | |
| Baudax Bio INC. | $24.64 | 2021 | |
| Endo USA, INC. | $24.32 | 2024 | Xiaflex |
| Anika Therapeutics, INC. | $15.81 | 2019 | |
| Daiichi Sankyo INC. | $13.87 | 2020 | |
| Baxter Healthcare | $12.27 | 2021 | |
| Gotham Surgical Solutions & Devices, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peteris Dzenis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.